Xenetic Biosciences (XBIO) Return on Sales (2023 - 2025)
Xenetic Biosciences (XBIO) has disclosed Return on Sales for 6 consecutive years, with 0.53% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Return on Sales rose 28.0% year-over-year to 0.53%, compared with a TTM value of 1.16% through Sep 2025, up 57.0%, and an annual FY2024 reading of 1.68%, up 10.0% over the prior year.
- Return on Sales was 0.53% for Q3 2025 at Xenetic Biosciences, up from 1.23% in the prior quarter.
- Across five years, Return on Sales topped out at 0.53% in Q3 2025 and bottomed at 2.48% in Q1 2024.
- Average Return on Sales over 3 years is 1.57%, with a median of 1.69% recorded in 2024.
- Peak annual rise in Return on Sales hit 106bps in 2024, while the deepest fall reached -97bps in 2024.
- Year by year, Return on Sales stood at 1.87% in 2023, then increased by 9bps to 1.69% in 2024, then soared by 69bps to 0.53% in 2025.
- Business Quant data shows Return on Sales for XBIO at 0.53% in Q3 2025, 1.23% in Q2 2025, and 1.59% in Q1 2025.